BMI View: Mozambique is a country rich in natural resources, which in turn has led to a rise in foreign
investments, aiding its economy in the long run. Although Mozambique currently suffers from a high burden
of diseases, with the government increasing its efforts in ..."
BMI View: Mozambique's abundance of natural resources has led to increasing foreign investments which
will benefit its economy in the future. However, the country struggles to meet the increasing demands on
pharmaceutical products and healthcare services. Drug scarcit ..."
BMI View: Mozambique's pharmaceuticals and healthcare market is typical of Sub-Saharan Africa. Public
healthcare provision, while improving, still falls short of meeting the demands of the population, and there
are wide gaps between the quality of care in urban and ru ..."
BMI View: Mozambique has made considerable progress in improving its healthcare and pharmaceuticals
market, and there are still many improvements ahead: the government's announcement this quarter that it
plans to offer young women the cervical cancer vaccine by 2014 illustrates ..."
BMI View: Mozambique's healthcare and pharmaceuticals market is reaping the benefits of the country's
economic growth and its appeal to international investors interested in its rich natural resources (mainly
gas). While the market is typical of many in the region - it has a hi ..."
BMI View: Strong real GDP growth and rich natural resources ensure that Mozambique remains a popular investment choice in the region. The country's pharmaceutical and healthcare sectors certainly benefit from the booming economy. Like many of its regional neighbours, Mozambique h ..."
Mozambique relies on drug imports to supply the majority of its domestic demand, but sinc e July 2012, has started limited national production of antiretrovirals at the state-owned Sociedade Moçambicana de Medicamentos (SMM). Supported by Brazil's Farmanguinhos, Mozambicans trave ..."
Mozambique relies on drug imports to supply the majority of its domestic demand, but since July 2012, has started limited national production of antiretrovirals at the state-owned Sociedade Moçambicana de Medicamentos (SMM). Supported by Brazil's F ..."